Form 8-K - Current report:
SEC Accession No. 0001493152-26-025646
Filing Date
2026-05-28
Accepted
2026-05-28 16:54:19
Documents
13
Period of Report
2026-05-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 45601
2 EX-10.1 ex10-1.htm EX-10.1 70901
  Complete submission text file 0001493152-26-025646.txt   343731

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE celu-20260521.xsd EX-101.SCH 3900
4 XBRL DEFINITION FILE celu-20260521_def.xml EX-101.DEF 26804
5 XBRL LABEL FILE celu-20260521_lab.xml EX-101.LAB 37062
6 XBRL PRESENTATION FILE celu-20260521_pre.xml EX-101.PRE 25428
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5635
Mailing Address 170 PARK AVE FLORHAM PARK NJ 07932
Business Address 170 PARK AVE FLORHAM PARK NJ 07932 (908) 768-2170
Celularity Inc (Filer) CIK: 0001752828 (see all company filings)

EIN.: 831702591 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38914 | Film No.: 261037493
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)